These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30909209)

  • 21. White matter hyperintensities, executive function and global cognitive performance in vascular mild cognitive impairment.
    Sudo FK; Alves CE; Alves GS; Ericeira-Valente L; Tiel C; Moreira DM; Laks J; Engelhardt E
    Arq Neuropsiquiatr; 2013 Jul; 71(7):431-6. PubMed ID: 23857627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Executive function and gait in older adults with cognitive impairment.
    Persad CC; Jones JL; Ashton-Miller JA; Alexander NB; Giordani B
    J Gerontol A Biol Sci Med Sci; 2008 Dec; 63(12):1350-5. PubMed ID: 19126848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trail Making Test errors in normal aging, mild cognitive impairment, and dementia.
    Ashendorf L; Jefferson AL; O'Connor MK; Chaisson C; Green RC; Stern RA
    Arch Clin Neuropsychol; 2008 Mar; 23(2):129-37. PubMed ID: 18178372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Odor identification and cognitive function in the Beaver Dam Offspring Study.
    Schubert CR; Cruickshanks KJ; Fischer ME; Huang GH; Klein R; Pankratz N; Zhong W; Nondahl DM
    J Clin Exp Neuropsychol; 2013; 35(7):669-76. PubMed ID: 23789858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical and Cognitive Stimulation Using an Exergame in Subjects with Normal Aging, Mild and Moderate Cognitive Impairment.
    Ben-Sadoun G; Sacco G; Manera V; Bourgeois J; König A; Foulon P; Fosty B; Bremond F; d'Arripe-Longueville F; Robert P
    J Alzheimers Dis; 2016 Jun; 53(4):1299-314. PubMed ID: 27372645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demographically adjusted trail making test norms in a Scandinavian sample from 41 to 84 years.
    Espenes J; Hessen E; Eliassen IV; Waterloo K; Eckerström M; Sando SB; Timón S; Wallin A; Fladby T; Kirsebom BE
    Clin Neuropsychol; 2020 Dec; 34(sup1):110-126. PubMed ID: 33034252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spatial navigation measured by the Floor Maze Test in patients with subjective cognitive impairment, mild cognitive impairment, and mild Alzheimer's disease.
    Tangen GG; Engedal K; Bergland A; Moger TA; Hansson O; Mengshoel AM
    Int Psychogeriatr; 2015 Aug; 27(8):1401-9. PubMed ID: 25644091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Shape Trail Test: application of a new variant of the Trail making test.
    Zhao Q; Guo Q; Li F; Zhou Y; Wang B; Hong Z
    PLoS One; 2013; 8(2):e57333. PubMed ID: 23437370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trail Making Test Elucidates Neural Substrates of Specific Poststroke Executive Dysfunctions.
    Muir RT; Lam B; Honjo K; Harry RD; McNeely AA; Gao FQ; Ramirez J; Scott CJ; Ganda A; Zhao J; Zhou XJ; Graham SJ; Rangwala N; Gibson E; Lobaugh NJ; Kiss A; Stuss DT; Nyenhuis DL; Lee BC; Kang Y; Black SE
    Stroke; 2015 Oct; 46(10):2755-61. PubMed ID: 26382176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Link between non hypoxemic chronic obstructive pulmonary disease and executive functioning in oldest old].
    Mora L; Sagot C; Dieudonné B; Faucounau V; Barrou Z; Breining A; Greffard S; Cohen-Bittan J; Verny M
    Geriatr Psychol Neuropsychiatr Vieil; 2015 Sep; 13(3):335-42. PubMed ID: 26395307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychological correlates of the P300 in patients with Alzheimer's disease.
    Lee MS; Lee SH; Moon EO; Moon YJ; Kim S; Kim SH; Jung IK
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():62-9. PubMed ID: 22940475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Impact of dysexecutive syndrome on autonomy in early Alzheimer's disease and Mild cognitive impairment].
    Jacus JP; Gély-Nargeot MC
    Geriatr Psychol Neuropsychiatr Vieil; 2014 Mar; 12(1):101-12. PubMed ID: 24647244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limitations of the trail making test part-B in assessing frontal executive dysfunction.
    Chan E; MacPherson SE; Robinson G; Turner M; Lecce F; Shallice T; Cipolotti L
    J Int Neuropsychol Soc; 2015 Feb; 21(2):169-74. PubMed ID: 25697352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-wide association study identified INSC gene associated with Trail Making Test Part A and Alzheimer's disease related cognitive phenotypes.
    Wang K; Xu C; Smith A; Xiao D; Navia RO; Lu Y; Xie C; Piamjariyakul U;
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110393. PubMed ID: 34224794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emphasizing speed or accuracy in an eye-tracking version of the Trail-Making-Test: Towards experimental diagnostics for decomposing executive functions.
    Recker L; Foerster RM; Schneider WX; Poth CH
    PLoS One; 2022; 17(9):e0274579. PubMed ID: 36094948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships Between Performance on Assessments of Executive Function and Fall Risk Screening Measures in Community-Dwelling Older Adults.
    Blackwood J; Shubert T; Forgarty K; Chase C
    J Geriatr Phys Ther; 2016; 39(2):89-96. PubMed ID: 26050194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of the apolipoprotein E genotype with memory performance and executive functioning in cognitively intact elderly.
    Luck T; Then FS; Luppa M; Schroeter ML; Arélin K; Burkhardt R; Thiery J; Löffler M; Villringer A; Riedel-Heller SG
    Neuropsychology; 2015 May; 29(3):382-387. PubMed ID: 25365563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Utility of the Trail-Making Test as a Predictor of Driving Performance in Older Adults.
    Papandonatos GD; Ott BR; Davis JD; Barco PP; Carr DB
    J Am Geriatr Soc; 2015 Nov; 63(11):2358-64. PubMed ID: 26503623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships between balance and cognition in patients with subjective cognitive impairment, mild cognitive impairment, and Alzheimer disease.
    Tangen GG; Engedal K; Bergland A; Moger TA; Mengshoel AM
    Phys Ther; 2014 Aug; 94(8):1123-34. PubMed ID: 24764071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of glaucoma on executive function and visual search.
    Lee SS; Wood JM; Black AA
    Ophthalmic Physiol Opt; 2020 May; 40(3):333-342. PubMed ID: 32189400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.